EUVIMEDEUVIMED entdecken
Fallbericht

Evaluation of central nervous system involvement in patients undergoing chimeric antigen receptor-engineered T-cell therapy by magnetic resonance imaging

F D Choque-Chávez, A Jareño-Badenas, D Benítez-Ribas, L Oleaga

Radiología (English Edition) · 2025

DOI: 10.1016/j.rxeng.2023.09.007 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Radiología (English Edition), 2025. Verfasst von F D Choque-Chávez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Radiología, Hospital Clínic de Barcelona, Barcelona, Spain. Electronic address: diegochoquechavez@gmail.com. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Immunotherapy, Adoptive, Receptors, Chimeric Antigen, Neurotoxicity Syndromes. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor-engineered (CAR) T-cell therapy is an effective immunotherapy for aggressive hematologic cancers. However, it can lead to complications such as immune effector cell-associated neurotoxicity syndrome (ICANS), or complications related to the immunosuppressive status of these patients. The role of imaging in this context is essential to help in ICANS diagnosis and to rule out other potential diagnosis, such as central nervous system infections. Two cases are presented to illustrate this clinical problem. CASE 1: describes a 38-year-old patient with diffuse large B-cell lymphoma who developed ICANS after CAR T-cell therapy. MRI revealed signs of leukoencephalopathy. Case 2 involves a 57-year-old patient with mantle-cell lymphoma who presented neurologic symptoms -clinically suggestive of ICANS- after CAR-T therapy. MRI showed signs indicative of limbic encephalitis. These two cases highlight the importance of MRI in clinical practice after CAR T-Cell Therapy underscoring the role of MRI in the diagnosis of complications in patients with neuropsychiatric symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance ImagingImmunotherapy, AdoptiveReceptors, Chimeric AntigenNeurotoxicity SyndromesHumansMiddle AgedAdultMaleFemaleLymphoma, Large B-Cell, Diffuse

Stichwörter der Autor:innen

CAR-TICANSImmunosuppressed hostImmunotherapyInmunosupresión del receptorInmunoterapiaLinfomaLymphomaNeurotoxicity syndromesSíndrome de neurotoxicidad

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Departamento de Radiología, Hospital Clínic de Barcelona, Barcelona, Spain. Electronic address: diegochoquechavez@gmail.com.
  • Departamento de Radiología, Hospital Clínic de Barcelona, Barcelona, Spain. Electronic address: ajarenba95@gmail.com.
  • Inmunología, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Departamento de Radiología, Hospital Clínic de Barcelona, Barcelona, Spain.

Zitieren

APA

Choque-Chávez, F. D., Jareño-Badenas, A., Benítez-Ribas, D., & Oleaga, L. (2025). Evaluation of central nervous system involvement in patients undergoing chimeric antigen receptor-engineered T-cell therapy by magnetic resonance imaging. Radiología (English Edition). https://doi.org/10.1016/j.rxeng.2023.09.007

Vancouver

Choque-Chávez FD, Jareño-Badenas A, Benítez-Ribas D, Oleaga L. Evaluation of central nervous system involvement in patients undergoing chimeric antigen receptor-engineered T-cell therapy by magnetic resonance imaging. Radiología (English Edition). 2025. doi:10.1016/j.rxeng.2023.09.007

BibTeX
@article{ChoqueChvez2025,
  author = {Choque-Chávez, F D and Jareño-Badenas, A and Benítez-Ribas, D and Oleaga, L},
  title = {Evaluation of central nervous system involvement in patients undergoing chimeric antigen receptor-engineered T-cell therapy by magnetic resonance imaging},
  journal = {Radiología (English Edition)},
  year = {2025},
  doi = {10.1016/j.rxeng.2023.09.007}
}
Kostenlos starten →